In the News
REBIScan, Inc., was founded in 2009 as the culmination of 20 years of research in pediatric vision scanning with the goal of bringing this technology into the hands of pediatricians worldwide. The company was the recipient of the second largest Phase I SBIR award from the National Eye Institute in 2010, and was named a finalist in the 2011 MassChallenge competition. With headquarters in Cambridge, MA, the company is poised to change the way children's vision is tested by providing technology that is easy to operate, cost-effective, and highly accurate and that can be deployed by pediatric practitioners in the medical home.
David G. Hunter, MD, PhD is founder, board member, and scientific advisor to REBIScan. Dr. Hunter is Ophthalmologist-in-Chief and the Richard M. Robb Chair of Ophthalmology at Children's Hospital Boston, President of the Children's Hospital Ophthalmology Foundation, Professor and Vice Chair of Ophthalmology at Harvard Medical School, Editor-in-Chief of the Journal of the American Association of Pediatric Ophthalmology and Strabismus, and the 2010–11 Vice President of the 12,000-member Association for Research in Vision and Ophthalmology. Dr. Hunter obtained a Bachelor of Science in electrical engineering from Rice University and a PhD (in Cell Biology) and MD from Baylor College of Medicine in Houston. After he completed an ophthalmology residency at Harvard's Mass Eye and Ear Infirmary, he was a fellow at the Wilmer Ophthalmological Institute, Johns Hopkins University, where he remained on faculty as Associate Professor of Ophthalmology and of Biomedical Engineering until 2002, when he was selected as Ophthalmologist-in-Chief at Children's. During his time at Children's, the Department of Ophthalmology at Children's Hospital Boston has grown to become the largest pediatric ophthalmology department in the nation and perhaps the world, with 30 full-time faculty, including 13 full-time and 3 affiliated MD ophthalmologists and 4 pediatric optometrists, with pediatric subspecialists in nearly every aspect of ophthalmology, as well as 7 full-time research faculty. The department also has created 7 endowed chairs as well as an endowed international observership to support clinical and basic research, teaching, and the worldwide dissemination of advances in pediatric ophthalmology and strabismus. Dr. Hunter is co-author of the book Last Minute Optics, which was recently released in its second edition.
Dr. Hunter's clinical and research interests focus on strabismus and amblyopia. He is collaborating with the laboratory of Elizabeth Engle, MD to study the genetic contributions of common and complex strabismus (including the congenital cranial dysinnervation disorders (CCDDs) such as congenital fibrosis of the extraocular muscles (CFEOM) and Duane syndrome.) His clinical expertise includes evaluation and correction of strabismus (misaligned eyes) in adults and children, including highly complex cases, and treatment of pediatric cataracts with intraocular lens implantation. He is developing new approaches to strabismus surgery for complex cases, including adjustable sutures that can be adjusted several days after surgery, and superior rectus transposition (SRT) for Duane syndrome and sixth nerve palsy (see "Aligning the Eyes" webcast). He has a special interest in treating amblyopia without eye patches (using eye drops instead), eye muscle surgery using adjustable sutures to increase accuracy (in adults and children in some cases), using botulinum toxin injections into extraocular muscles to avoid eye muscle surgery, and diagnosing and treating strabismus that develops after other types of eye surgery in adults. He has been listed as a Best Doctor in Boston Magazine and Boston Now.
Justin G. Shaka is a co-founder of REBIScan. Mr. Shaka joined the company after serving as Financial Analyst to the Ophthalmology Foundation at Children's Hospital Boston, managing over $25M in research funds and endowments. While at Children's, he was also appointed to a 3-year post on the Editorial Administration of the Journal of AAPOS, the official publication of the American Association for Pediatric Ophthalmology and Strabismus, and the leading international peer-reviewed journal for scientific advances in pediatric ophthalmology, and he managed finances for a startup optical shop, which became profitable in its second year of operation. Mr. Shaka received his MBA from the Tepper School of Business at Carnegie Mellon University, where he was elected President of the Entrepreneurship and Venture Capital Club, named Swartz Fellow of Entrepreneurship, and, in 2011, awarded the Canfield-Roseman Entrepreneur-of-the-Year. He was also an advisor and founding Board Member of IACT, a Pittsburgh, PA initiative to bring industry, academics, and clinicians together to encourage collaborative innovation within healthcare. Mr. Shaka received his bachelor's degree in Economics from the University of New Hampshire, and is a member of Phi Beta Kappa.
Website design by Danielle Spencer, 2012.